Protein homeostasis relies on an intricate network of cellular pathways that balance the accurate synthesis of proteins with degradation and the removal of misfolded proteins, a hallmark of neurodegenerative diseases. One mechanism for maintaining the proteome's fidelity is modulating the rate at which the ribosome synthesizes proteins, which is important for ensuring proper protein folding. A key regulator of this rate is elongation factor-2 (eEF-2), an essential component of the translation elongation machinery that catalyzes the ribosome's movement along the mRNA. The function of eEF-2 is inhibited through phosphorylation by the calmodulin-dependent eukaryotic elongation factor-2 kinase (eEF-2K). Many cellular signaling pathways, such as those activated by growth factors or nutrient deprivation, phosphorylate eEF-2K to regulate its activity towards eEF-2. The mechanism by which these cellular signals control eEF-2K activity to modulate elongation rates is poorly understood. These phosphorylations are primarily concentrated on a large, intrinsically disordered region in eEF-2K, termed the regulatory loop. We hypothesized that the regulatory loop acts to negatively regulate the affinity of eEF-2K for its essential activator, calmodulin (CaM), and that phosphorylations on this loop may modulate its conformation, allowing for dynamic control of eEF-2K activation by CaM in response to cellular cues. To address this, we created a version of eEF-2K with the regulatory loop removed (ΔR eEF-2K). In cells, this construct shows higher activity towards eEF-2 and increased co-immunoprecipitated CaM. We also found a 10-fold increase in the apparent affinity of CaM for the recombinant ΔR eEF-2K compared to WT eEF-2K. This data supports a mechanism in which the regulatory loop acts as a suppressive element in eEF-2K by reducing its affinity for CaM. Next, we incorporated phosphorylation into the regulatory loop of recombinant eEF-2K at Ser359, a mTORC1-dependent inhibitory phosphorylation site. We found that the P-Ser359 resulted in a 5-fold decrease in the apparent affinity of CaM. To determine if this mechanism was relevant in cells, we immunoprecipitated eEF-2K from cells grown normally or from cells starved of nutrients and growth factors — a treatment known to activate eEF-2K and remove inhibitory phosphorylations, including Ser359. We found an approximately 18-fold increase in the apparent affinity of CaM for eEF-2K from starved cells. Taken together, our data support a mechanism where the regulatory loop and inhibitory phosphorylation of the loop reduce the affinity of eEF-2K for CaM, potentially explaining how eEF-2K activity is suppressed under normal cellular conditions. Our data also reveals that activation of the cellular enzyme via starvation is correlated with the removal of inhibitory phosphorylations and a significant increase in the affinity of eEF-2K for CaM. These findings give insight into the regulatory mechanisms that allow eEF-2K to remarkably integrate signals from upstream nutrient and energy-sensing cellular pathways to ultimately control protein synthesis rates. This work is supported by NIH award R01 GM123252.
No takes yet. Share an insight, caveat, or question.
Bohanon et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: